These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23254454)

  • 1. A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
    Tissot AC; Spohn G; Jennings GT; Shamshiev A; Kurrer MO; Windak R; Meier M; Viesti M; Hersberger M; Kündig TM; Ricci R; Bachmann MF
    Eur J Immunol; 2013 Mar; 43(3):716-22. PubMed ID: 23254454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
    Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
    Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
    Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
    J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
    Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
    Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel vaccines targeting interleukin-1 receptor type I.
    Zhou Y; Huang J; Mai W; Kuang W; Li X; Shi D; Yang Y; Wu J; Wu Z; Liao Y; Zhou Z; Qiu Z
    Int Immunopharmacol; 2024 May; 132():111941. PubMed ID: 38554439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
    Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
    Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
    Zhou Y; Wang S; Qiu Z; Song X; Pan Y; Hu X; Zhang H; Deng Y; Ding D; Wu H; Yang S; Wang M; Zhou Z; Liao Y; Chen X
    J Hypertens; 2016 Mar; 34(3):474-85; discussion 485. PubMed ID: 26771341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Hida S; Sagara J; Taniguchi S; Takahashi M
    Biochem Biophys Res Commun; 2012 Aug; 425(2):162-8. PubMed ID: 22819845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice.
    Usui F; Kimura H; Ohshiro T; Tatsumi K; Kawashima A; Nishiyama A; Iwakura Y; Ishibashi S; Takahashi M
    Biochem Biophys Res Commun; 2012 Mar; 420(1):72-7. PubMed ID: 22402284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α.
    Kamari Y; Shaish A; Shemesh S; Vax E; Grosskopf I; Dotan S; White M; Voronov E; Dinarello CA; Apte RN; Harats D
    Biochem Biophys Res Commun; 2011 Feb; 405(2):197-203. PubMed ID: 21219852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.
    Kirii H; Niwa T; Yamada Y; Wada H; Saito K; Iwakura Y; Asano M; Moriwaki H; Seishima M
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):656-60. PubMed ID: 12615675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Davenport P; Tipping PG
    Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
    Dunér P; To F; Beckmann K; Björkbacka H; Fredrikson GN; Nilsson J; Bengtsson E
    Cardiovasc Res; 2011 Aug; 91(3):528-36. PubMed ID: 21493703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
    Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
    Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice.
    Noh JR; Lee IK; Kim YH; Gang GT; Hwang JH; Ly SY; Yun BS; Lee CH
    Ann Nutr Metab; 2011; 59(2-4):145-53. PubMed ID: 22142871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
    Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
    Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.